This article is all about what’s new and what it might mean for us, covering the latest in genetics in news. New methods like ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

CRISPR Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 71 to 82.

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...

KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell ...

It might be time to look a bit off the beaten path, at names that can stand up to any AI-stock-led correction.

Hosts David and Gina explore how scientists over the centuries unlocked the ability to edit our genes ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate CRISPR Therapeutics AG before investing. In this article, we go over a few key ...

Northwestern scientists have developed a new nanostructure that supercharges CRISPR’s ability to safely and efficiently enter cells, potentially unlocking its full power to treat genetic diseases. By ...